Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001493152-25-006465·LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Schedule 13G ownership disclosure
LIXTE BIOTECHNOLOGY HLDGS IN
Common Stock, par value $0.0001 per share · CUSIP: 539319301
Event date: 2025-02-11
- Filing-level shares
- 217,392.00
- Percent of class
- 8.1%
- Orca Capital AG
Shares: 217,392.00 · Class: 8.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-006465
- Form type
- SCHEDULE 13G
- Filer
- LIXTE BIOTECHNOLOGY HOLDINGS, INC.
- CIK
- CIK 1335105
- Filed
- Feb 13, 2025
- Reporting period
- Feb 11, 2025
- Description
- Schedule 13G beneficial ownership